Pulse Biosciences (PLSE) Net Shares Issued and Repurchased (2016 - 2025)
Pulse Biosciences (PLSE) posted Net Shares Issued and Repurchased of $2.9 million for Q4 2025, up 11.69% on a QoQ basis from $2.6 million in Q1 2025, and down 3.61% year-over-year from $3.0 million in Q4 2024.
Analysis
Pulse Biosciences (PLSE) Net Shares Issued and Repurchased (2016 - 2025) Analysis & Trends
Pulse Biosciences has reported Net Shares Issued and Repurchased for 10 years, with the latest figure at $2.9 million in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased fell 3.61% year-over-year to $2.9 million in Q4 2025; TTM through Dec 2025 was $2.9 million, a 3.61% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 3.61% from the prior year.
- Net Shares Issued and Repurchased was $2.9 million for Q4 2025 at Pulse Biosciences, up from $2.6 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $5.3 million in Q4 2023, with the low at $608815.0 in Q1 2021.
- Average Net Shares Issued and Repurchased over 5 years is $1.9 million, with a median of $1.4 million recorded in 2021.
- The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased tumbled 43.45% in 2024, then surged 307.68% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $1.2 million in 2021, then climbed by 18.78% to $1.5 million in 2022, then jumped by 262.57% to $5.3 million in 2023, then sank by 43.45% to $3.0 million in 2024, then dropped by 3.61% to $2.9 million in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $2.9 million (Q4 2025), $2.6 million (Q1 2025), and $3.0 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Pulse Biosciences | 3.76 Bn | 3.76 Bn | 161,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.91 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 639,000.00 |
| Dec 31, 2023 | 5.34 Mn |
| Mar 31, 2023 | 807,300.00 |
| Dec 31, 2022 | 1.47 Mn |
| Mar 31, 2022 | 819,229.00 |
| Dec 31, 2021 | 1.24 Mn |
| Mar 31, 2021 | 608,815.00 |
| Dec 31, 2020 | 1.97 Mn |
| Mar 31, 2020 | 178,000.00 |
| Dec 31, 2019 | 1.16 Mn |
| Jun 30, 2019 | 31,875.00 |
| Mar 31, 2019 | 174,303.00 |
| Dec 31, 2018 | 657,375.00 |
| Jun 30, 2018 | 192,500.00 |
| Mar 31, 2018 | 50,000.00 |
| Dec 31, 2017 | 1.55 Mn |
| Mar 31, 2017 | 58,000.00 |